Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis

被引：0
|
作者：
Brian J Schmidt
Fergal P Casey
Thomas Paterson
Jason R Chan
机构：
[1] Entelos Holding Corporation,
来源：
BMC Bioinformatics | / 14卷
关键词：
Drug development; Mechanistic modeling; Biosimulation; Patient population; Biomarker; Pharmaceutical research & development; Personalized medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A Whole-Blood Transcriptomic Signature Predicts Clinical Response to Rituximab in Rheumatoid Arthritis
    Sellam, Jeremie
    Marion-Thore, Sandrine
    Dumont, F.
    Letourneur, Franck
    Rouanet, Stephanie
    Taoufik, Yassine
    Sibilia, Jean
    Tebib, Jacques G.
    Le Loet, Xavier
    Combe, Bernard G.
    Dougados, Maxime
    Mariette, Xavier
    Chiocchia, Gilles
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S976 - S976
  • [32] Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters
    de Jong, Tamarah D.
    Blits, Marjolein
    de Ridder, Sander
    Vosslamber, Saskia
    Wolbink, Gertjan
    Nurmohamed, Mike T.
    Verweij, Cornelis L.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [33] Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters
    Tamarah D. de Jong
    Marjolein Blits
    Sander de Ridder
    Saskia Vosslamber
    Gertjan Wolbink
    Mike T. Nurmohamed
    Cornelis L. Verweij
    Arthritis Research & Therapy, 18
  • [34] INDUCTION OF IFN TYPE I BIOLOGY FOLLOWING THERAPY DETERMINES CLINICAL RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS
    Vosslamber, Saskia
    Raterman, Hennie G.
    Kraan, Tineke C. T. M. van der Pouw
    Schreurs, Marco W. J.
    von Blomberg, B. Mary E.
    Nurmohamed, Michael T.
    Lems, Willem F.
    Dijkmans, Ben A. C.
    Voskuyl, Alexandre E.
    Verweij, Cornelis L.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70
  • [35] Type I interferon signature in the initiation of the immune response in vitiligo
    Bertolotti, Antoine
    Boniface, Katia
    Vergier, Beatrice
    Mossalayi, Djavad
    Taieb, Alain
    Ezzedine, Khaled
    Seneschal, Julien
    PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (03) : 398 - 407
  • [36] PREDICTIVE FACTORS OF RESPONSE TO RITUXIMAB THERAPY MODIFY THE ACCELERATED ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Benucci, M.
    Saviola, G.
    Manfredi, M.
    Atzeni, F.
    Puttini, P. Sarzi
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 192 - 192
  • [37] Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital
    Couderc, M.
    Mathieu, S.
    Pereira, B.
    Glace, B.
    Soubrier, M.
    ARTHRITIS CARE & RESEARCH, 2013, 65 (04) : 648 - 652
  • [38] The type I interferon signature determines the sustained anticitrullinated protein antibodies levels during TNFα blockade in rheumatoid arthritis
    Cantaert, Tineke
    van Baarsen, Lisa G.
    Wijbrandts, Carla A.
    van de Sande, Marleen G.
    Kraan, Tineke van der Pouw
    Verweij, Cor L.
    Tak, Paul P.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S517 - S517
  • [39] Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
    Kraan, T. C. T. M. van der Pouw
    Wijbrandts, C. A.
    van Baarsen, L. G. M.
    Voskuyl, A. E.
    Rustenburg, F.
    Baggen, J. M.
    Ibrahim, S. M.
    Fero, M.
    Dijkmans, B. A. C.
    Tak, P. P.
    Verweij, C. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (08) : 1008 - 1014
  • [40] Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: Assignment of a type I interferon signature in a subpopulation of patients
    Kraan, T. C. T. M. van der Pouw
    Wijbrandts, C. A.
    van Baarsen, L. G.
    Voskuyl, A. E.
    Rustenburg, F.
    Baggen, J. M.
    Fero, M.
    Dijkmans, B. A. C.
    Tak, P. P.
    Verweij, C. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A8 - A8
12345